Methods of administering N- (5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-m orpholin4-yl-ethoxy)imidazo[2,1-b][1,3]benzothi azol-2-yl]phenyl}urea to treat proliferative disease
Details for Australian Patent Application No. 2008325141 (hide)
International Classifications
Event Publications
18 March 2010 PCT application entered the National Phase
PCT publication WO2009/061446 Priority application(s): WO2009/061446
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008325142-Use of umbilical cord blood in the treatment of premature birth complications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser